CPhaMAS:基于优化的参数拟合算法进行药理学数据分析的在线平台
Yun Kuang1, Dong-Sheng Cao2, Yong-Hui Zuo3
1Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China; XiangYa School of Pharmaceutical Sciences, Central South University, Changsha, 410083, China.
CPhaMAS提供了一个易于使用的药理动力学分析平台,具有优化的Nelder-Mead算法,用于药物开发中准确的参数估计. 该工具简化了研究人员和临床医生的复杂数据分析.
科学领域:
- 药理学和药物开发领域
- 计算生物学和生物信息学
- 生物统计学 生物统计学
背景情况:
- 临床药理学建模软件至关重要,但通常具有的学习曲线.
- 现有的算法与个体差异和测量错误作斗争,阻碍了准确的药理动力学参数估计.
- 对于药物开发和个性化治疗,需要具有强大的参数匹配的用户友好型工具.
研究的目的:
- 开发一个优化的参数拟合算法,对初始值不那么敏感.
- 将这个算法集成到一个名为CPhaMAS的用户友好的在线平台中,用于药理动力学数据分析.
- 与现有软件相比,评估CPhaMAS平台的性能和准确性.
主要方法:
- 开发了一个优化的Nelder-Mead方法,其中包括简单顶点的重新初始化,以避免局部解决方案.
- 优化的算法被集成到CPhaMAS平台中,该平台包括用于隔间模型分析,非隔间分析 (NCA) 和生物等价性/生物可用性 (BE/BA) 分析的模块.
- 评估了CPhaMAS平台,并与已建立的WinNonlin软件进行了比较.
主要成果:
- CPhaMAS展示了易于使用,不需要编程知识.
- 优化的Nelder-Mead方法在CPhaMAS中显示出优异的准确性 (较低的平均相对误差,较高的R2),与WinNonlin相比,在两和外血管模型中,即使具有异常的初始值.
- 与WinNonlin相比,CPhaMAS中NCA参数计算的平均相对误差为<0.0001%,不同类型药物的BE计算显示关键参数 (Cmax,AUCt,AUCinf) 的平均相对误差为<0.01% .
结论:
- CPhaMAS 是一个用户友好且准确的药理动力学数据分析平台.
- 集成的优化算法提高了参数估计的可靠性.
- CPhaMAS是药物开发和精密医学的宝贵工具.
更多相关视频
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
08:43PTR-ToF-MS Coupled with an Automated Sampling System and Tailored Data Analysis for Food Studies: Bioprocess Monitoring, Screening and Nose-space Analysis
Published on: May 11, 2017
相关概念视频
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
